ADIPONECTIN LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND EXCESS BODY WEIGHT: RELATIONSHIP WITH METABOLIC PARAMETERS

dc.contributor.authorAmonov Mukhammad Komil ugli
dc.date.accessioned2025-12-28T10:43:40Z
dc.date.issued2025-06-24
dc.description.abstractThe article presents the results of an experimental study aimed at examining adiponectin levels in patients with chronic kidney disease (CKD) and excess body weight, as well as their relationship with metabolic parameters. A negative correlation was found between serum adiponectin concentration and body mass index (BMI), triglyceride levels, and CKD stage. These data highlight the role of adiponectin as a potential marker of metabolic disorders in this patient population.
dc.formatapplication/pdf
dc.identifier.urihttps://usajournals.org/index.php/1/article/view/584
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/4022
dc.language.isoeng
dc.publisherModern American Journals
dc.relationhttps://usajournals.org/index.php/1/article/view/584/642
dc.rightshttps://creativecommons.org/licenses/by/4.0
dc.sourceModern American Journal of Medical and Health Sciences; Vol. 1 No. 3 (2025); 226-229
dc.source3067-803X
dc.titleADIPONECTIN LEVELS IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND EXCESS BODY WEIGHT: RELATIONSHIP WITH METABOLIC PARAMETERS
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
ugli_2025_adiponectin_levels_in_patients_with_chro.pdf
item.page.filesection.size
326.21 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections